These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1292701)
21. Optimal photodynamic band of red light in hematoporphyrin derivative (HPD) photoradiation therapy of cancer. Pimstone NR; Gandhi SN Prog Clin Biol Res; 1984; 170():673-8. PubMed ID: 6241707 [No Abstract] [Full Text] [Related]
22. Morphological study of the combined effect of purpurin derivatives and light on transplantable rat bladder tumors. Morgan AR; Garbo GM; Kreimer-Birnbaum M; Keck RW; Chaudhuri K; Selman SH Cancer Res; 1987 Jan; 47(2):496-8. PubMed ID: 3791237 [TBL] [Abstract][Full Text] [Related]
23. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine. Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323 [TBL] [Abstract][Full Text] [Related]
24. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671 [TBL] [Abstract][Full Text] [Related]
25. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection. O'Riordan K; Akilov OE; Chang SK; Foley JW; Hasan T Photochem Photobiol Sci; 2007 Oct; 6(10):1117-23. PubMed ID: 17914486 [TBL] [Abstract][Full Text] [Related]
26. Experimental design for the evaluation of the antitumor action of cytokines. Ciolli V; Sestili P; Brigato M; Gabriele L; Varano F; Locardi C; Belardelli F Ann Ist Super Sanita; 1990; 26(3-4):441-51. PubMed ID: 2091505 [TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy in general surgery. Vietri F; Girolami M; Illuminati G; Belbusti M; Guglielmi R; Reddi E; Jori G G Chir; 1991; 12(6-7):367-70. PubMed ID: 1751324 [TBL] [Abstract][Full Text] [Related]
28. Purpurinimides as photosensitizers: effect of the presence and position of the substituents in the in vivo photodynamic efficacy. Rungta A; Zheng G; Missert JR; Potter WR; Dougherty TJ; Pandey RK Bioorg Med Chem Lett; 2000 Jul; 10(13):1463-6. PubMed ID: 10888333 [TBL] [Abstract][Full Text] [Related]
30. Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II. Khanum F; Jain V Indian J Exp Biol; 1997 Apr; 35(4):348-55. PubMed ID: 9315233 [TBL] [Abstract][Full Text] [Related]
31. Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats. Olivier D; Bourré L; El-Sabbagh E; Loussouarn D; Simonneaux G; Valette F; Patrice T Surg Neurol; 2007 Sep; 68(3):255-63; discussion 263. PubMed ID: 17544487 [TBL] [Abstract][Full Text] [Related]
32. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808 [TBL] [Abstract][Full Text] [Related]
33. Detection of photodynamic therapy-induced early apoptosis in human salivary gland tumor cells in vitro and in a mouse tumor model. Kaneko T; Chiba H; Yasuda T; Kusama K Oral Oncol; 2004 Sep; 40(8):787-92. PubMed ID: 15288832 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model. Dube A; Sharma S; Gupta PK Oral Oncol; 2006 Jan; 42(1):77-82. PubMed ID: 16140565 [TBL] [Abstract][Full Text] [Related]
35. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma. Winther JB Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429 [TBL] [Abstract][Full Text] [Related]
36. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Hoffman RM Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987 [TBL] [Abstract][Full Text] [Related]
37. Current clinical and preclinical photosensitizers for use in photodynamic therapy. Detty MR; Gibson SL; Wagner SJ J Med Chem; 2004 Jul; 47(16):3897-915. PubMed ID: 15267226 [No Abstract] [Full Text] [Related]
38. An experimental model comparing the antineoplastic and the immunosuppressive effects of some cytostatics. Ghyka G; Haraga L Arch Roum Pathol Exp Microbiol; 1989; 48(1):33-45. PubMed ID: 2802968 [TBL] [Abstract][Full Text] [Related]
39. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316 [TBL] [Abstract][Full Text] [Related]
40. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy. Hu M; Brasseur N; Yildiz SZ; van Lier JE; Leznoff CC J Med Chem; 1998 May; 41(11):1789-802. PubMed ID: 9599230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]